L Molé

4.2k total citations · 1 hit paper
57 papers, 3.3k citations indexed

About

L Molé is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, L Molé has authored 57 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 24 papers in Hepatology and 23 papers in Infectious Diseases. Recurrent topics in L Molé's work include Hepatitis C virus research (24 papers), HIV/AIDS drug development and treatment (20 papers) and Hepatitis B Virus Studies (18 papers). L Molé is often cited by papers focused on Hepatitis C virus research (24 papers), HIV/AIDS drug development and treatment (20 papers) and Hepatitis B Virus Studies (18 papers). L Molé collaborates with scholars based in United States, Australia and Canada. L Molé's co-authors include Lisa I. Backus, Pamela S. Belperio, Troy A. Shahoumian, Barbara Phillips, Derek Boothroyd, Timothy P. Loomis, Mark Holodniy, James Halloran, A. Clinton White and Linda Rabeneck and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

L Molé

55 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Retention in Care: A Challenge to Survival with HIV Infection

2007 472 citations Thomas P. Giordano, Allen L. Gifford et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L Molé United States	26	2.3k	1.7k	1.3k	526	328	57	3.3k
Pablo Labarga Spain	36	2.2k 0.9×	2.1k 1.2×	2.0k 1.5×	849 1.6×	617 1.9×	137	3.8k
Andrew H. Talal United States	35	2.6k 1.2×	2.9k 1.7×	1.2k 0.9×	1.3k 2.4×	183 0.6×	141	5.1k
Stefan Mauss Germany	40	4.1k 1.8×	4.3k 2.6×	1.8k 1.4×	683 1.3×	503 1.5×	191	5.6k
Brian Conway Canada	25	1.5k 0.6×	1.3k 0.8×	889 0.7×	458 0.9×	124 0.4×	86	2.1k
Susanna Naggie United States	33	2.1k 0.9×	1.8k 1.1×	1.0k 0.8×	180 0.3×	284 0.9×	129	3.0k
Jennifer J. Kiser United States	32	1.3k 0.6×	585 0.3×	2.5k 1.9×	1.1k 2.0×	403 1.2×	107	3.5k
François Dabis France	28	1.4k 0.6×	492 0.3×	2.4k 1.8×	1.4k 2.7×	969 3.0×	67	3.3k
Arthur Y. Kim United States	38	2.7k 1.2×	3.3k 1.9×	1.2k 0.9×	658 1.3×	132 0.4×	121	4.9k
Karam Mounzer United States	30	974 0.4×	416 0.2×	1.4k 1.0×	1.4k 2.6×	471 1.4×	117	3.0k
Eva Wolf Germany	24	803 0.4×	452 0.3×	867 0.7×	480 0.9×	297 0.9×	108	2.3k

Countries citing papers authored by L Molé

Since Specialization

Citations

This map shows the geographic impact of L Molé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Molé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Molé more than expected).

Fields of papers citing papers by L Molé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Molé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Molé. The network helps show where L Molé may publish in the future.

Co-authorship network of co-authors of L Molé

This figure shows the co-authorship network connecting the top 25 collaborators of L Molé. A scholar is included among the top collaborators of L Molé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Molé. L Molé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharma, Aditya, Gina Oda, Michael Icardi, L Molé, & Mark Holodniy. (2021). Implementation of large-scale laboratory-based detection of COVID-19 in the Veterans Health Administration, March 2020 – February 2021. Diagnostic Microbiology and Infectious Disease. 102(3). 115617–115617. 2 indexed citations

Belperio, Pamela S., Troy A. Shahoumian, Timothy P. Loomis, L Molé, & Lisa I. Backus. (2018). Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3. Journal of Hepatology. 70(1). 15–23. 63 indexed citations

Bhattacharya, Debika, Pamela S. Belperio, Troy A. Shahoumian, et al.. (2017). Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1–Coinfected Patients Treated in Routine Practice. Clinical Infectious Diseases. 64(12). 1711–1720. 59 indexed citations

Backus, Lisa I., Pamela S. Belperio, Troy A. Shahoumian, Timothy P. Loomis, & L Molé. (2016). Real‐world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment‐naive, genotype 1 hepatitis C‐infected patients. Hepatology. 64(2). 405–414. 131 indexed citations

Backus, Lisa I., Pamela S. Belperio, Troy A. Shahoumian, Timothy P. Loomis, & L Molé. (2016). 501 Comparative Effectiveness of Ledipasvir/Sofosbuvir±Ribavirin and Ombitasvir/Paritaprevir/Ritonavir+Dasabuvir±Ribavirin in 6,961 Genotype 1 Patients Treated in Routine Medical Practice. Gastroenterology. 150(4). S1036–S1036. 1 indexed citations

Backus, Lisa I., Pamela S. Belperio, Troy A. Shahoumian, Timothy P. Loomis, & L Molé. (2015). Effectiveness of sofosbuvir‐based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans. Alimentary Pharmacology & Therapeutics. 42(5). 559–573. 76 indexed citations

Backus, Lisa I., Pamela S. Belperio, Troy A. Shahoumian, & L Molé. (2014). Impact of Provider Type on Hepatitis C Outcomes With Boceprevir-based and Telaprevir-based Regimens. Journal of Clinical Gastroenterology. 49(4). 329–335. 12 indexed citations

Belperio, Pamela S., et al.. (2013). Early Virologic Responses and Hematologic Safety of Direct-Acting Antiviral Therapies in Veterans With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology. 11(8). 1021–1027. 19 indexed citations

Backus, Lisa I., Derek Boothroyd, Barbara Phillips, et al.. (2011). A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C. Clinical Gastroenterology and Hepatology. 9(6). 509–516.e1. 361 indexed citations

10.

Backus, Lisa I., Derek Boothroyd, Barbara Phillips, et al.. (2010). National Quality Forum Performance Measures for HIV/AIDS Care. Archives of Internal Medicine. 170(14). 1239–46. 38 indexed citations

11.

Backus, Lisa I., С. Г. Гаврилов, Timothy P. Loomis, et al.. (2009). Clinical Case Registries: Simultaneous Local and National Disease Registries for Population Quality Management. Journal of the American Medical Informatics Association. 16(6). 775–783. 96 indexed citations

12.

Giordano, Thomas P., Allen L. Gifford, A. Clinton White, et al.. (2007). Retention in Care: A Challenge to Survival with HIV Infection. Clinical Infectious Diseases. 44(11). 1493–1499. 472 indexed citations breakdown →

13.

Backus, Lisa I., Derek Boothroyd, Barbara Phillips, & L Molé. (2007). Predictors of response of U.S. veterans to treatment for the hepatitis C virus. Hepatology. 46(1). 37–47. 182 indexed citations

14.

Braithwaite, R. Scott, Michael J. Kozal, Chung Chang, et al.. (2007). Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS. 21(12). 1579–1589. 102 indexed citations

15.

Fultz, Shawn L., Melissa Skanderson, L Molé, et al.. (2006). Development and Verification of a “Virtual” Cohort Using the National VA Health Information System. Medical Care. 44(8). S25–S30. 227 indexed citations

16.

Backus, Lisa I., Derek Boothroyd, Barbara Phillips, & L Molé. (2006). Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus. Journal of Viral Hepatitis. 13(12). 799–810. 18 indexed citations

17.

Backus, Lisa I., L Molé, Sophia W. Chang, & Lawrence Deyton. (2001). The immunology case registry. Journal of Clinical Epidemiology. 54(12). S12–S15. 47 indexed citations

18.

Molé, L, et al.. (1999). Decreased Medical Expenditures for Care of HIV-Seropositive Patients. PharmacoEconomics. 16(3). 307–315. 24 indexed citations

19.

Molé, L, et al.. (1997). The Impact of Active Herpes Simplex Virus Infection on Human Immunodeficiency Virus Load. The Journal of Infectious Diseases. 176(3). 766–770. 190 indexed citations

20.

Staal, Frank J. T., Mario Roederer, Dennis Israelski, et al.. (1992). Intracellular Glutathione Levels in T Cell Subsets Decrease in HIV-Infected Individuals. AIDS Research and Human Retroviruses. 8(2). 305–311. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact